LEPTIN - ANVISA Registration 80564740021

Access comprehensive regulatory information for LEPTIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80564740021 and manufactured by DIASOURCE IMMUNOASSAYS S.A. The registration is held by CECON CENTRO DE CONTRÔLE E PRODUTOS PARA DIAGNÓSTICOS LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DRG INTERNATIONAL, INC., DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80564740021
Registration Details
ANVISA Registration Number: 80564740021
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

LEPTINA EASIA
Risk Class II

Registration Details

80564740021

25351695341201403

46273637000152

Company Information

Belgium
PT: BÉLGICA

Dates and Status

Feb 02, 2015

VIGENTE

09/18/2025 19:00:01